IP Library › Granted Patent US 12,296,123
Granted Patent B2
US 12,296,123 · App. 18/212,880 · Granted May 13, 2025

Methods and devices for urethral treatment

Inventor: Yair Feld (Haifa, IL)
Assignee: ProArc Medical Ltd.
A61M29/00A61M25/00A61M29/02A61B18/1815A61B2018/1861A61F2002/048
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,296,123
App. No.
18/212,880
Granted
May 13, 2025
Kind
B2
Abstract

Apparatus and methods are described for dilating a portion of a urethra surrounded by an enlarged prostate. The apparatus includes dilation device, and a delivery device including a balloon. The delivery device is configured to deliver the dilation device and the balloon to the portion of the urethra, while the dilation device is disposed in a helical configuration on the delivery device. Upon the balloon and the dilation device being disposed at the portion of the urethra, the delivery device is configured to expand the balloon, thereby expanding the portion of the urethra, and to cause the dilation device to radially expand from the helical configuration to an arc configuration. Subsequently, the delivery device is configured to implant the dilation device, from outside the balloon, into tissue of the prostate surrounding the portion of the urethra, while the portion of the urethra is expanded by the balloon.

Claims (25)

1. An apparatus for dilating a portion of a urethra surrounded by an enlarged prostate, the apparatus comprising:

a dilation device; and

a delivery device comprising a balloon,

the delivery device being configured:

to deliver the dilation device and the balloon to the portion of the urethra, while the dilation device is disposed in a helical configuration on the delivery device, and

upon the balloon and the dilation device being disposed at the portion of the urethra:

to expand the balloon, thereby expanding the portion of the urethra,

to cause the dilation device to radially expand from the helical configuration to an arc configuration, and

subsequently, to implant the dilation device, from outside the balloon, into tissue of the prostate surrounding the portion of the urethra, while the portion of the urethra is expanded by the balloon.

2. The apparatus according to claim 1 , wherein the delivery device is configured to implant the dilation device into the tissue of the prostate surrounding the portion of the urethra by screwing the dilation device into the tissue of the prostate surrounding the portion of the urethra.

3. The apparatus according to claim 1 , wherein the delivery device is configured to implant the dilation device into the tissue of the prostate surrounding the portion of the urethra by pushing the dilation device into the tissue of the prostate surrounding the portion of the urethra.

4. The apparatus according to claim 1 , wherein the delivery device comprises an overtube, and wherein the delivery device is configured to implant the dilation device into the tissue of the prostate surrounding the portion of the urethra by advancing the dilation device into the tissue of the prostate surrounding the portion of the urethra using the overtube.

5. The apparatus according to claim 1 , wherein the dilation device is configured to expand post-implantation.

6. The apparatus according to claim 1 , wherein the dilation device comprises one or more separate arcuate-shaped sections.

7. The apparatus according to claim 1 , wherein the dilation device comprises a material configured to expand outwardly around the urethra during and/or after implantation.

8. The apparatus according to claim 1 , wherein the balloon is configured to shape the urethra prior to or during the implanting of the dilation device.

9. The apparatus according to claim 1 , wherein the delivery device is configured not to rotate the balloon during the implanting of the dilation device.

10. The apparatus according to claim 1 , wherein the dilation device is sized such that, upon being implanted into the tissue of the prostate surrounding the portion of the urethra, the dilation device does not interfere with an inner bladder valve.

11. The apparatus according to claim 1 , wherein the dilation device is sized such that, upon being implanted into the tissue of the prostate surrounding the portion of the urethra, the dilation device provides clearance between the enlarged prostate and a lumen of the urethra and prevents recompression of the urethra due to further enlargement of the prostate.

12. The apparatus according to claim 11 , wherein the dilation device is sized such that, upon being implanted into the tissue of the prostate surrounding the portion of the urethra, there is a portion of the urethra that is not surrounded by the dilation device at the bottom of the urethra.

13. The apparatus according to claim 1 , wherein the dilation device has a substantially flat cross-section.

14. The apparatus according to claim 1 , wherein the dilation device comprises a plastically-deformable material and the delivery device is configured to cause the dilation device to radially expand from the helical configuration to the arc configuration by inflating the balloon.

15. The apparatus according to claim 1 , wherein the dilation device comprises an elastically-deformable material, wherein the delivery device comprises a mounting device configured to hold the dilation device within the delivery device, and wherein the delivery device is configured to cause the dilation device to radially expand from the helical configuration to the arc configuration by releasing the dilation device from the mounting device.

16. The apparatus according to claim 1 , wherein the dilation device is sized such that, upon being implanted into the tissue of the prostate surrounding the portion of the urethra, no more than 30% by angle of the portion of the urethra is not surrounded by the dilation device.

17. The apparatus according to claim 16 , wherein the dilation device is sized such that, upon being implanted into the tissue of the prostate surrounding the portion of the urethra, there is a portion of the urethra that is not surrounded by the dilation device at the bottom of the urethra.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2023
From: FELD, YAIR
To: PROARC MEDICAL LTD.
Reel/Frame 064068/0558 →
Continuity (5)
Continuation 16554774 · Aug 29, 2019
Continuation 14967308 · Dec 13, 2015
Division 13257651
Provisional Application 61202634 · Mar 20, 2009
Related Publication 20230330401A1 · Oct 19, 2023
References Cited (148)
US 3726279A · Barefoot · 1973 [cited by examiner]
US 4660560A · Klein · 1987 [cited by applicant]
US 5030227A · Rosenbluth et al. · 1991 [cited by applicant]
US 5133713A · Huang et al. · 1992 [cited by applicant]
US 5269802A · Garber · 1993 [cited by applicant]
US 5643340A · Nunokawa · 1997 [cited by applicant]
US 5674242A · Phan et al. · 1997 [cited by applicant]
US 5766203A · Imran et al. · 1998 [cited by applicant]
US 5921982A · Lesh et al. · 1999 [cited by applicant]
US 6070589A · Keith et al. · 2000 [cited by applicant]
US 6319282B1 · Nishi · 2001 [cited by applicant]
US 6673101B1 · Fitzgerald et al. · 2004 [cited by applicant]
US 7004965B2 · Gross · 2006 [cited by applicant]
US 7279002B2 · Shaw et al. · 2007 [cited by applicant]
US 7632297B2 · Gross · 2009 [cited by applicant]
US 8016845B1 · Sauer · 2011 [cited by applicant]
US 8145321B2 · Gross · 2012 [cited by applicant]
US 8840660B2 · Weber · 2014 [cited by applicant]
US 10406333B2 · Feld · 2019 [cited by applicant]
US 20020007222A1 · Desai · 2002 [cited by applicant]
US 20020010489A1 · Grayzel et al. · 2002 [cited by applicant]
US 20020032486A1 · Lazarovitz et al. · 2002 [cited by applicant]
US 20020032488A1 · Brekke et al. · 2002 [cited by applicant]
US 20020035391A1 · Mikus et al. · 2002 [cited by applicant]
US 20020072761A1 · Abrams · 2002 [cited by examiner]
US 20030055313A1 · Anderson et al. · 2003 [cited by applicant]
US 20030060870A1 · Reever · 2003 [cited by applicant]
US 20030069467A1 · Lau et al. · 2003 [cited by applicant]
US 20030167088A1 · Abraham et al. · 2003 [cited by applicant]
US 20030191479A1 · Thornton · 2003 [cited by applicant]
US 20030216814A1 · Siegel et al. · 2003 [cited by applicant]
US 20030225420A1 · Wardle · 2003 [cited by examiner]
US 20040030217A1 · Yeung et al. · 2004 [cited by applicant]
US 20040064139A1 · Yossepowitch · 2004 [cited by applicant]
US 20040181235A1 · Daignault et al. · 2004 [cited by applicant]
US 20050055087A1 · Starksen · 2005 [cited by applicant]
US 20050137716A1 · Gross · 2005 [cited by applicant]
US 20050163821A1 · Sung et al. · 2005 [cited by applicant]
US 20060095058A1 · Sivan et al. · 2006 [cited by applicant]
US 20060149308A1 · Melsheimer et al. · 2006 [cited by applicant]
US 20060167540A1 · Masters et al. · 2006 [cited by applicant]
US 20060173517A1 · Gross · 2006 [cited by applicant]
US 20060229711A1 · Yan et al. · 2006 [cited by applicant]
US 20060271151A1 · Mcgarry et al. · 2006 [cited by applicant]
US 20060276871A1 · Lamson et al. · 2006 [cited by applicant]
US 20070093781A1 · Kugler et al. · 2007 [cited by applicant]
US 20080065209A1 · Pflueger · 2008 [cited by examiner]
US 20090018523A1 · Lamson et al. · 2009 [cited by applicant]
US 20090156977A1 · Daignault et al. · 2009 [cited by applicant]
US 20090264987A1 · Gale · 2009 [cited by applicant]
US 20090297582A1 · Meyer et al. · 2009 [cited by applicant]
US 20100100195A1 · Gross · 2010 [cited by applicant]
US 20100130815A1 · Sade et al. · 2010 [cited by applicant]
US 20100137893A1 · Kilemnick et al. · 2010 [cited by applicant]
US 20100292715A1 · Nering et al. · 2010 [cited by applicant]
US 20100312054A1 · Beyar et al. · 2010 [cited by applicant]
US 20120010645A1 · Feld · 2012 [cited by applicant]
US 20130268086A1 · Creedon et al. · 2013 [cited by applicant]
US 20140012192A1 · Bar-On et al. · 2014 [cited by applicant]
US 20160000455A1 · Golan et al. · 2016 [cited by applicant]
US 20160096009A1 · Feld · 2016 [cited by applicant]
US 20180344995A1 · Bar-On et al. · 2018 [cited by applicant]
US 20190125516A1 · Lamson et al. · 2019 [cited by applicant]
US 20190381291A1 · Feld · 2019 [cited by applicant]
EP 0125352A1 · 1984 [cited by applicant]
EP 1413262A1 · 2004 [cited by applicant]
EP 1415681A1 · 2004 [cited by applicant]
JP 2004147812A · 2004 [cited by applicant]
WO 9404081A1 · 1994 [cited by applicant]
WO 0143664A1 · 2001 [cited by applicant]
WO 2007048437A1 · 2007 [cited by applicant]
WO 2007109621A2 · 2007 [cited by applicant]
WO 2008056194A1 · 2008 [cited by applicant]
WO 2008142677A2 · 2008 [cited by applicant]
WO 2010106543A2 · 2010 [cited by applicant]
WO 2012123950A2 · 2012 [cited by applicant]
WO 2014141278A1 · 2014 [cited by applicant]
WO 2021250588A1 · 2021 [cited by applicant]
WO 2024003851A1 · 2024 [cited by applicant]
Examination Report for European Application No. 18215225.6 mailed Nov. 2, 2023. [cited by applicant]
Final Office Action for U.S. Appl. No. 16/048,481 mailed Nov. 6, 2023. [cited by applicant]
Issue Notification for U.S. Appl. No. 16/554,774 mailed Jul. 26, 2023. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/048,481 mailed Nov. 2, 2023. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 17/533,306 mailed Oct. 31, 2023. [cited by applicant]
Corrected Notice of Allowability for U.S. Appl. No. 17/533,306 mailed Jan. 31, 2024. [cited by applicant]
International Search Report and Written Opinion from International Application No. PCT/IB2023/056813 mailed Sep. 28, 2023. [cited by applicant]
Issue Notification for U.S. Appl. No. 17/533,306 mailed Feb. 21, 2024. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/048,481 mailed Feb. 26, 2024. [cited by applicant]
Advisory Action for U.S. Appl. No. 13/257,651 mailed Nov. 30, 2018. [cited by applicant]
Advisory Action for U.S. Appl. No. 14/005,330 mailed Dec. 27, 2017. [cited by applicant]
Applicant-Initiated Interview Summary for U.S. Appl. No. 13/257,651 mailed Jan. 16, 2017. [cited by applicant]
Applicant-Initiated Interview Summary for U.S. Appl. No. 14/005,330 mailed Apr. 28, 2016. [cited by applicant]
Applicant-Initiated Interview Summary for U.S. Appl. No. 14/005,330 mailed Mar. 15, 2017. [cited by applicant]
Applicant-Initiated Interview Summary for U.S. Appl. No. 14/005,330 mailed Nov. 9, 2017. [cited by applicant]
Applicant-Initiated Interview Summary for U.S. Appl. No. 14/005,330 mailed Oct. 6, 2016. [cited by applicant]
Applicant-Initiated Interview Summary for U.S. Appl. No. 14/768,766 mailed Feb. 4, 2019. [cited by applicant]
Applicant-Initiated Interview Summary for U.S. Appl. No. 14/967,308 mailed Feb. 12, 2019. [cited by applicant]
Communication Pursuant to Article 94(3) EPC for European Application No. 10714484.2 mailed Feb. 21, 2017. [cited by applicant]
Communication Pursuant to Article 94(3) EPC for European Application No. 12716658.5 mailed Mar. 23, 2016. [cited by applicant]
Communication Pursuant to Article 94(3) EPC for European Application No. 12716658.5 mailed Sep. 24, 2014. [cited by applicant]
Communication Pursuant to Article 94(3) EPC for European Application No. 14764625.1 mailed Oct. 28, 2019. [cited by applicant]
Communication Relating to the Results of the Partial International Search for International Application No. PCT/ IL2010/000229 mailed Nov. 8, 2010. [cited by applicant]
Communication Relating to the Results of the Partial International Search for International Application No. PCT/ IL2012/050094 mailed Jul. 4, 2012. [cited by applicant]
European Search Report and Search Opinion for European Application No. 18215225.6 mailed Jan. 17, 2020. [cited by applicant]
Examiner-Initiated Interview Summary for U.S. Appl. No. 14/005,330 mailed Nov. 29, 2016. [cited by applicant]
Final Office Action for U.S. Appl. No. 13/257,651 mailed Apr. 19, 2017. [cited by applicant]
Final Office Action for U.S. Appl. No. 13/257,651 mailed Jul. 16, 2018. [cited by applicant]
Final Office Action for U.S. Appl. No. 13/257,651 mailed Mar. 16, 2015. [cited by applicant]
Final Office Action for U.S. Appl. No. 13/257,651 mailed Mar. 24, 2016. [cited by applicant]
Final Office Action for U.S. Appl. No. 14/005,330 mailed Aug. 18, 2017. [cited by applicant]
Final Office Action for U.S. Appl. No. 14/005,330 mailed Aug. 24, 2016. [cited by applicant]
Final Office Action for U.S. Appl. No. 14/768,766 mailed Apr. 2, 2021. [cited by applicant]
Final Office Action for U.S. Appl. No. 14/768,766 mailed Aug. 23, 2021. [cited by applicant]
Final Office Action for U.S. Appl. No. 14/768,766 mailed Jul. 29, 2019. [cited by applicant]
Final Office Action for U.S. Appl. No. 14/967,308 mailed Dec. 13, 2018. [cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/IL2010/000229 mailed Sep. 29, 2011. [cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/IL2012/050094 mailed Sep. 26, 2013. [cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/IL2014/050281 mailed Sep. 24, 2015. [cited by applicant]
International Search Report and Written Opinion from International Application No. PCT/IL2010/000229 mailed Jan. 18, 2011. [cited by applicant]
International Search Report and Written Opinion from International Application No. PCT/IL2012/050094 mailed Sep. 13, 2012. [cited by applicant]
International Search Report and Written Opinion from International Application No. PCT/IL2014/050281 mailed Jul. 3, 2014. [cited by applicant]
International Search Report and Written Opinion from International Application No. PCTIB2021055063 mailed Aug. 10, 2021. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 13/257,651 mailed Aug. 12, 2014. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 13/257,651 mailed Sep. 15, 2015. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 13/257,651 mailed Sep. 8, 2017. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 13/257,651 mailed Sep. 9, 2016. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 14/005,330 mailed Feb. 16, 2016. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 14/005,330 mailed Mar. 1, 2017. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 14/768,766 mailed Jul. 22, 2020. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 14/768,766 mailed Nov. 19, 2018. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 14/967,308 mailed Mar. 28, 2018. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/048,481 mailed Mar. 11, 2022. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/554,774 mailed Jun. 8, 2022. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/554,774 mailed Mar. 22, 2023. [cited by applicant]
Rectification of Obvious Mistake Under Rule 91.1. for International Application No. PCT/1L2010/000229 mailed Jul. 6, 2010. [cited by applicant]
Requisition by Examiner from the Innovation, Science and Economic Development Canada for Canadian Application No. 2,938,823 mailed Apr. 3, 2020. [cited by applicant]
Restriction Requirement for U.S. Appl. No. 13/257,651 mailed Apr. 22, 2014. [cited by applicant]
Restriction Requirement for U.S. Appl. No. 14/005,330 mailed Jul. 14, 2015. [cited by applicant]
Restriction Requirement for U.S. Appl. No. 14/768,766 mailed Apr. 20, 2018. [cited by applicant]
Restriction Requirement for U.S. Appl. No. 14/967,308 mailed Nov. 30, 2017. [cited by applicant]
Restriction Requirement for U.S. Appl. No. 16/554,774 mailed Feb. 4, 2022. [cited by applicant]
Supplementary European Search Report and the European Search Opinion for European Application No. 14764625.1 mailed Oct. 28, 2016. [cited by applicant]
U.S. Appl. No. 14/768,766, filed Aug. 19, 2015. [cited by applicant]
U.S. Appl. No. 14/967,308, filed Dec. 13, 2015. [cited by applicant]
U.S. Appl. No. 16/554,774, filed Aug. 29, 2019. [cited by applicant]
U.S. Appl. No. 17/533,306, filed Nov. 23, 2021. [cited by applicant]
U.S. Appl. No. 61/202,634, filed Mar. 20, 2009. [cited by applicant]
U.S. Appl. No. 63/036,548, filed Jun. 9, 2020. [cited by applicant]
Cited By (1)
US 12,678,308